Cargando…
Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is mainly associated with myosin, heavy chain 7 (MYH7) and myosin binding protein C, cardiac (MYBPC3) mutations. In order to better explain the clinical and genetic heterogeneity in HCM patients, in this study, we implemented a target-next generation sequencing (NGS...
Autores principales: | Cecconi, Massimiliano, Parodi, Maria I., Formisano, Francesco, Spirito, Paolo, Autore, Camillo, Musumeci, Maria B., Favale, Stefano, Forleo, Cinzia, Rapezzi, Claudio, Biagini, Elena, Davì, Sabrina, Canepa, Elisabetta, Pennese, Loredana, Castagnetta, Mauro, Degiorgio, Dario, Coviello, Domenico A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029966/ https://www.ncbi.nlm.nih.gov/pubmed/27600940 http://dx.doi.org/10.3892/ijmm.2016.2732 |
Ejemplares similares
-
The natural history of hypertrophic cardiomyopathy
por: Autore, Camillo, et al.
Publicado: (2020) -
Old and new therapeutic solutions in the treatment of hypertrophic cardiomyopathy
por: Autore, Camillo, et al.
Publicado: (2023) -
Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015) -
Left Ventricular Remodeling in Hypertrophic Cardiomyopathy: An Overview of Current Knowledge
por: Musumeci, Beatrice, et al.
Publicado: (2021) -
Clinical course of hypertrophic cardiomyopathy patients implanted with a transvenous or subcutaneous defibrillator
por: Francia, Pietro, et al.
Publicado: (2023)